Dermata Therapeutics, Inc. DRMA
Set alert
At close · Oct 30
After hours · Oct 30, 7:59 PM ET
- YTD
- -66.59%
- 1 year
- -77.41%
- Open
- 0.799
- Prev close
- 0.8302
- Mkt cap
- 3.84M
- Vol
- 62.20K
- Avg vol
- 3.44M
- EPS
- -4.39
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.7637
- High
- 0.829
- Forward P/E
- -0.32
- Beta
- 0.79
- Short ratio
- 0.52
- Inst. own
- 0.66%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.27
- 200-d avg
- 2.84
- 1y target
- 6.00
News
-
2 days ago benzinga.com
Dermata Therapeutics Enrolls First Participant In Its Clinical Trial Evaluating Tome Clearing Treatment For Acne; Expects To Launch This Second Commercial Product In H1 2027
The initiation of this clinical trial marks another milestone in Dermata's strategy by adding a second product to its Tome skincare portfolio, targeting significant opportunities in the consumer…
2 weeks ago benzinga.com
Why Is Dermata Therapeutics Stock Gaining Thursday?
Dermata Therapeutics (DRMA) jumps 34% after positive clinical results for its weekly Bioneedle Tome Foundational Treatment.
2 weeks ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Regencell Bioscience (NASDAQ:RGC) stock increased by 30.4% to $10.58 during Thursday's regular session. The company's market cap stands at $4.0 billion. SenesTech (NASDAQ:SNES) stock rose…
-
2 weeks ago benzinga.com
Dermata Therapeutics Announces Over 71% Of Patients Had Overall Skin Improvements At Day 29 In Its Cosmetic Clinical Trial Of Tome Foundational Treatment
Dermata Therapeutics, Inc. (NASDAQ:DRMA) ("Dermata," or the "Company"), a science-driven leader in dermatologic solutions, today announced positive topline results from its recently completed cosmetic
2 weeks ago accessnewswire.com
Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment
- Once-weekly Tome Foundational Treatment demonstrated improvements across key measures of skin appearance after four treatments - - Over 71% of study participants were graded as having overall…
1 month ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers InnovAge Holding (NASDAQ:INNV) shares increased by 10.8% to $11.65 during Tuesday's after-market session. The company's market cap stands at $1.4 billion. The company's, Q4 earnings came out…
2 months ago accessnewswire.com
Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment
- Tome Foundational Treatment, powered by Bioneedle™, is now available for purchase at www.tomeskincare.com - - Once-weekly Foundational Treatment is designed to renew the appearance of skin and…
2 months ago accessnewswire.com
Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch
- Preorders can be made by visiting www.tomeskincare.com - - Dermata is ready to begin shipping orders on the expected launch date of August 25, 2026 - - Tome Foundational Treatment is a once-weekly…
2 months ago accessnewswire.com
Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
$3.4 million upfront with up to approximately $6.7 million of potential additional gross proceeds upon the exercise in full of warrants SAN DIEGO, CA / ACCESS Newswire / August 17, 2026 / Dermata…
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.9% to $0.17 during Thursday's pre-market session. The company's market cap stands at $7.2 million. LENSAR (NASDAQ:LNSR) shares…
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers BioVie (NASDAQ:BIVI) shares increased by 39.4% to $1.77 during Wednesday's regular session. The market value of their outstanding shares is at $9.5 million. Sionna Therapeutics (NASDAQ:SION)…
2 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Bone Biologics (NASDAQ:BBLG) stock moved upwards by 17.7% to $1.07 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.6 million. Definium Therapeutics
2 months ago benzinga.com
Dermata Therapeutics Stock Surges 27% Pre-Market: Why is it Moving?
Dermata Therapeutics shares jumped 28.73% pre-market after reporting second-quarter results and preparing for its upcoming skincare product launch.
2 months ago benzinga.com
Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
CRWV shares rose in pre-market trading after reporting better-than-expected Q2 results. BAOS, BOXL, DOGZ, DRMA, ZBAO, HYLN, XHLD, VELO, and HRB also saw gains.
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Dermata Therapeutics (NASDAQ:DRMA) stock moved upwards by 44.4% to $1.56 during Tuesday's after-market session. The company's market cap stands at $4.5 million. As per the news, the Q2…
2 months ago accessnewswire.com
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026
- Dermata announced the launch date of its first commercial product, Tome™ Foundational Treatment, expected on August 25, 2026 - - Dermata recently attended Be+Well Beauty and Wellness Show in Las…
2 months ago accessnewswire.com
Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment
- A new chapter in skincare has arrived - - This will be Dermata's first commercial product launch, planned for August 25, 2026 - - Join the waitlist at tomeskincare.com - SAN DIEGO, CA / ACCESS…
-
5 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
-
5 months ago benzinga.com
Dermata Therapeutics Q1 EPS $(0.48) Beats $(0.53) Estimate
Dermata Therapeutics (NASDAQ:DRMA) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.53) by 9.43 percent. This is a 89.33 percent increase over losses of…
5 months ago accessnewswire.com
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026
- Dermata announced their Tome Skincare brand for direct-to-consumer ("DTC") skincare products - - Dermata plans to launch its first DTC product, the Tome Foundational Treatment, a once-weekly mask…
-
7 months ago benzinga.com
Dermata Therapeutics Secures Australian Patent Acceptance For Bioneedle System In Dermal Fillers
- This would be Dermata's first patent, if issued, covering the use of its Bioneedle Delivery System ("BDS") with dermal fillers -- The Company also has allowed and issued patents in the US,…
7 months ago accessnewswire.com
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System
- This would be Dermata's first patent, if issued, covering the use of its Bioneedle Delivery System ("BDS") with dermal fillers - - The Company also has allowed and issued patents in the US,…
-
7 months ago benzinga.com
Dermata Therapeutics Q4 EPS $(1.52) Beats $(1.54) Estimate
Dermata Therapeutics (NASDAQ:DRMA) reported quarterly losses of $(1.52) per share which beat the analyst consensus estimate of $(1.54) by 1.3 percent. This is a 83.48 percent increase over losses of…
7 months ago accessnewswire.com
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025
- Dermata announced a strategic pivot to develop and commercialize direct-to-consumer ("DTC") skincare products under the brand name Tome - - Dermata plans to launch its first DTC product, our…
7 months ago defenseworld.net
Head-To-Head Review: Pliant Therapeutics (NASDAQ:PLRX) versus Dermata Therapeutics (NASDAQ:DRMA)
Dermata Therapeutics (NASDAQ: DRMA - Get Free Report) and Pliant Therapeutics (NASDAQ: PLRX - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast…
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
7 months ago benzinga.com
Dermata Shares Rise After USPTO Issues Patent Notice Of Allowance
Dermata Therapeutics shares are trading higher Friday after the USPTO issued a notice of allowance for a patent on skin condition treatment.
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
7 months ago benzinga.com
Why Planet Labs Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Planet Labs (PL) stock rose in pre-market trading after better-than-expected Q4 sales and strong FY27 guidance. Top gainers include JDZG, AZTR, YYGH, DRMA, WNW, RPGL, JEM, FDX, and FLY. Top losers…
7 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
7 months ago benzinga.com
UPDATE: Dermata Therapeutics Has Received A Notice Of Allowance For A U.S. Patent Titled "COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS"
UPDATE: Dermata Therapeutics Has Received A Notice Of Allowance For A U.S. Patent Titled "COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS"
7 months ago accessnewswire.com
Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing
- Kyra Peckaitis will lead the launch of Dermata's recently announced Tome skincare brand - SAN DIEGO, CA / ACCESS Newswire / March 10, 2026 / Dermata Therapeutics, Inc. ("Dermata," or the "Company")…
7 months ago defenseworld.net
Dermata Therapeutics (DRMA) Projected to Post Earnings on Monday
Dermata Therapeutics (NASDAQ: DRMA - Get Free Report) is expected to issue its results before the market opens on Monday, March 16th. Analysts expect the company to announce earnings of ($1.54) per…
8 months ago accessnewswire.com
Dermata Opens a New Chapter with the Release of Tome Skincare
-The oldest new thing in skincare - - Dermata expects to launch its first product in the middle of 2026 - SAN DIEGO, CA / ACCESS Newswire / March 5, 2026 / Dermata Therapeutics, Inc.…
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
8 months ago benzinga.com
Why Comfort Systems Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Why Comfort Systems Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
-
9 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
-
9 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
-
9 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
-
9 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
9 months ago benzinga.com
The Australian Patent Office Grants Dermata Therapeutics' Patent Application for Its Spongilla Technology Combination as a Method for Treating Acne
The Company's innovative acne kit represents a new approach to acne treatment by targeting the underlying acne-causing mechanisms with enhanced precision and effectiveness. Unlike traditional…
9 months ago accessnewswire.com
Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office
This patent grant follows the Company's U.S. issued patent, covering its Spongilla technology combination as a method to topically treat acne Dermata expects to launch a new once-weekly,…
10 months ago benzinga.com
Why OceanFirst Financial Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Why OceanFirst Financial Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
-
10 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
10 months ago feeds.benzinga.com
Stock Market Today: S&P 500, Dow Jones Futures Trade Mixed Amid Blip In Santa Claus Rally—Boeing, Freeport-McMoRan, Fonar In Focus
U.S. stock futures swung between gains and losses on Tuesday after Monday's declines. Futures of major benchmark indices were mixed. The Santa Claus rally, which began on Dec. 24 last week, seems to…
10 months ago benzinga.com
Stock Market Today: S&P 500, Dow Jones Futures Trade Mixed Amid Blip In Santa Claus Rally—Boeing, Freeport-McMoRan, Fonar In Focus
U.S. stock futures swung between gains and losses on Tuesday after Monday’s declines. Futures of major benchmark indices were mixed. The Santa Claus rally, which began on Dec. 24 last week, seems to…
10 months ago benzinga.com
Why Fonar Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
Why Fonar Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
10 months ago feeds.benzinga.com
Verastem, TEN Holdings And 3 Stocks To Watch Heading Into Tuesday
U.S. stock futures mixed on Tuesday, potential stocks to watch: TEN Holdings up 17%, Fonar up 24%, CapsoVision down 11%.